Study

EORTC-1522-QLG

Development of an EORTC questionnaire for individuals at risk for a Hereditary Cancer Predisposition Syndrome : the EORTC QLQ-HCPSxx

Study documentation Back to result

Trial Status

Recruiting

Dates

Date of activation: 15-May-2017

Data management at EORTC

None

Design

QoL Mod. development
Not randomized / N.A.

Targeted Sample size

Treatment

Study Staff

  • Anne Oberguggenberger (Study Coordinator), A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck
  • Vasilios Vasiliou (Study Coordinator, Study Co-Coordinator), Bank Of Cyprus Oncology Centre, Strovolos - Nicosia
  • Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels

Type of cancer

Participating groups

  • EORTC Quality of Life Group

Protocol summary

http://clinicaltrials.gov/study/

NCT number